Viemed Healthcare, Inc.

Viemed Healthcare, Inc.

VMDNYSE / NASDAQHealthcareSmall cap

$8.52-$0.09 (-1.0%)

Last close · Data as of Nov 20, 2026

Market cap
$377.2M
P/E
25.3x
EV / EBITDA
7.4x
Revenue
$270.3M
Net margin
5.5%
ROCE
13.1%

+34.2% over the last year

Viemed Healthcare, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-13.1%
3M
-0.6%
6M
-12.0%
1Y
+34.2%
5Y
+56.3%

52-week range

Day change -$0.09 (-1.0%) from $8.61 to $8.52 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in VMD, bought on each weekday since 2021.

News & filings

What Viemed Healthcare filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthOperating profit was 19.4 times interest costs.

Concerns

No concern stands out for this company on the data on file.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

Read moreShow less

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Sector
Healthcare
Shares outstanding
38.0M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$377.2M
P/E
25.3x
P/B
2.7x
EV / EBITDA
7.4x
EV / Sales
1.4x
P/S
1.4x
52-week high
$12.33
52-week low
$6.35

Profitability

Operating margin
7.7%
Net margin
5.5%
EBITDA margin
19.1%
ROE
10.6%
ROCE
13.1%
ROIC
11.1%
ROA
7.5%
Asset turnover
1.36

Growth

Revenue
$270.3M
Revenue growth, 1Y
20.5%
Revenue CAGR, 3Y
24.9%
Net profit growth, 1Y
32.6%
Free cash flow
$11.9M

Solvency

Current ratio
1.18
Debt / Equity
0.11
Debt / Assets
0.08
CFO / Net profit
3.48
Cash / Market cap
3.6%

Where the revenue went

Of every $100 of FY2025 revenue, $6 was left as net income.

Viemed Healthcare, Inc. income statement flow, FY2025
Viemed Healthcare, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$114.8M
RevenueGross profit$155.5M
Gross profitResearch and development$3.0M
Gross profitSelling, general and administrative$130.5M
Gross profitOther operating expenses$1.2M
Gross profitOperating income$20.7M
Operating incomePretax income$20.7M
Interest and other incomePretax income$1.1M
Pretax incomeTax and other$6.8M
Pretax incomeNet income$14.9M

Revenue and net profit

Revenue grew 20.5% in FY2025; net profit is the dashed line.

Viemed Healthcare, Inc. revenue and net profit by fiscal year
Viemed Healthcare, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$138.8M$6.2M
FY2023$183.0M$10.2M
FY2024$224.3M$11.3M
FY2025$270.3M$14.9M

Cash flows

FY2025: $51.9M from operations, $11.9M free after investment (dashed).

Viemed Healthcare, Inc. operating and free cash flow by fiscal year
Viemed Healthcare, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$27.7M$4.8M
FY2023$45.2M$19.1M
FY2024$39.1M$1.3M
FY2025$51.9M$11.9M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$270.3M+20.5%1Y
EBITDA
$51.6M+21.9%1Y
Net profit
$14.9M+32.6%1Y
Cash from operations
$51.9M+32.8%1Y
Free cash flow
$11.9M+805.2%1Y
Revenue CAGR, 3Y
24.9%
Net profit CAGR, 3Y
33.9%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$270.3M$51.6M$14.9M$11.9M10.6%+20.5%+32.6%

Monthly returns

Month-by-month returns of VMD across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$199.2M
Liabilities$55.6M
Equity$143.5M
Paid-in capital$21.7M
Retained earnings$102.9M
Minority interest$2.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; VMD highlighted.

P/E against peers

VMD trades at 25.3x earnings against a peer median of -5.8x.

  1. Viemed Healthcare, Inc. (this company)25.3x

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): Compass Therapeutics, Inc., Benitec Biopharma Inc., Lexeo Therapeutics, Inc., Perspective Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Viemed Healthcare, Inc.VMDthis company$377.2M25.3x2.7x10.6%7.4x
OmniAb, Inc.OABI$385.6M-6.0x1.4x-24.3%-8.1x
Compass Therapeutics, Inc.CMPX$383.6M-5.8x1.9x-33.8%-5.1x
Benitec Biopharma Inc.BNTC$379.6M-10.0x3.9x-39.0%-6.8x
CapsoVision, Inc.CV$376.7M-14.9x28.4x-190.9%-14.7x
Vanda Pharmaceuticals Inc.VNDA$375.8M—1.1x-67.4%—
Lexeo Therapeutics, Inc.LXEO$375.3M-3.8x1.5x-40.5%-3.3x
Delcath Systems, Inc.DCTH$372.5M138.0x3.3x2.4%327.0x
Perspective Therapeutics, Inc.CATX$370.7M-3.6x1.8x-49.8%-3.4x
Peer median—-5.8x1.9x-39.7%-5.1x

Year-to-date ROI

VMD since 1 January, against earlier years.

Historical volatility

VMD's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Viemed Healthcare, Inc. operating margin by fiscal year
Viemed Healthcare, Inc. operating margin by fiscal year
DateOperating margin
FY20226.2%
FY20238.2%
FY20247.1%
FY20257.7%
LineFY2025
Cost of revenueCost Of Revenue$114.8M
Gross profitGross Profit$155.5M
Operating expensesOperating Expense$134.8M
Research and developmentResearch And Development$3.0M
Other operating expensesOther Operating Expenses-$250.0k
Depreciation and amortisationDepreciation And Amortization In Income Statement$1.5M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$1.5M
Depreciation income statementDepreciation Income Statement—
Total expensesTotal Expenses$249.6M
Pretax incomePretax Income$21.8M

Learn while you research

Academy chapters picked for Viemed Healthcare, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Growth Investing21% revenue growth is in the top tier, learn how to value growth.7 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →